✦ LIBER ✦

Double-blind comparison of etodolac sustained-release tablets and diclofenac sustained-release tablets in patients with rheumatoid arthritis: An interim report

✍ Scribed by F. Porzio; M. Schattenkirchner

Book ID: 117090503
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 524 KB
Volume: 53
Category: Article
ISSN: 0011-393X
DOI: 10.1016/s0011-393x(05)80239-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-blind comparison of etodolac sust

Double-blind comparison of etodolac sustained-release tablets and piroxicam capsules in patients with rheumatoid arthritis: An interim report

✍ R.W. Jubb; P. Platt; T.R. Price 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 562 KB

Meta-analysis of two double-blind compar

Meta-analysis of two double-blind comparative studies with the sustained-release form of etodolac in rheumatoid arthritis

✍ F. Porzio 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 572 KB

Comparative efficacy and tolerability of

Comparative efficacy and tolerability of two sustained-release formulations of diclofenac: results of a double-blind, randomised study in patients with osteoarthritis and a reappraisal of diclofenac's use in this patient population*

✍ Wagenitz, Andreas; Mueller, Edgar A.; Frentzel, Adrian; Cambon, Nathalie 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 401 KB

A double-blind comparison of parenteral

A double-blind comparison of parenteral methotrexate and parenteral gold in the treatment of early erosive rheumatoid arthritis: An interim report on 102 patients after 12 months

✍ R. Rau; G. Herborn; T. Karger; H. Menninger; D. Elhardt; J. Schmitt 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 822 KB

Rapid and sustained improvement in bone

Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone

✍ Patrick Garnero; Elizabeth Thompson; Thasia Woodworth; Josef S. Smolen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 3 views

## Abstract ## Objective To investigate the effects of tocilizumab (TCZ) added to a stable dosage of methotrexate (MTX) on biochemical markers of bone and cartilage metabolism in patients in the multicenter double‐blind, placebo‐controlled OPTION (Tocilizumab Pivotal Trial in Methotrexate Inadequa